Answer
Octanate LV replaces deficient factor VIII, temporarily correcting the deficiency in haemophilia A; activated factor VIII helps factor IX activate factor X, which generates thrombin so fibrinogen can become fibrin and form a clot.
Sources for this answer
- OctanateLV 100 IU/mL Powder and solvent for solution for injectionOctapharma Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked